1-(4-(2-(4-Fluorophenyl)imidazo[1,2-a]pyrimidin-7-yl)-1,4-diazepan-1-yl)ethanone

ID: ALA4587697

Chembl Id: CHEMBL4587697

PubChem CID: 155566559

Max Phase: Preclinical

Molecular Formula: C19H20FN5O

Molecular Weight: 353.40

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(=O)N1CCCN(c2ccn3cc(-c4ccc(F)cc4)nc3n2)CC1

Standard InChI:  InChI=1S/C19H20FN5O/c1-14(26)23-8-2-9-24(12-11-23)18-7-10-25-13-17(21-19(25)22-18)15-3-5-16(20)6-4-15/h3-7,10,13H,2,8-9,11-12H2,1H3

Standard InChI Key:  XWEUCDXQARJJIK-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4587697

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 353.40

Molecular Weight (Monoisotopic): 353.1652

AlogP: 2.59

#Rotatable Bonds: 2

Polar Surface Area: 53.74

Molecular Species: NEUTRAL

HBA: 5

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 2.43

CX LogP: 1.82

CX LogD: 1.82

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.71

Np Likeness Score: -2.12

References

1. Mantipally M, Gangireddy MR, Gundla R, Badavath VN, Mandha SR, Maddipati VC..  (2019)  Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.,  29  (16): [PMID:31239178] [10.1016/j.bmcl.2019.06.031]

Source

Source(1):

• Scientific Literature